Carisma Therapeutics, Inc. (CARM)

Carisma Therapeutics Revenue

Carisma Therapeutics had revenue of $10.77M in the twelve months ending June 30, 2025, down -48.01% year-over-year. In the year 2024, Carisma Therapeutics had annual revenue of $19.63M with 31.59% growth.

• Revenue (ttm): 10.77M
• Revenue Growth: -48.01%
• P/S Ratio: 0.04
• Revenue / Employee: 1.14M
• Employees: 46
• Market Cap: 2.09M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	19.63M	4.71M	31.59%
Dec 31, 2023	14.92M	5.09M	51.71%
Dec 31, 2022	9.83M	-16.71M	-62.95%
Dec 31, 2021	26.54M	15.31M	136.24%
Dec 31, 2020	11.24M	-	-
Dec 31, 2019	-	-	-
Dec 31, 2018	-	-	-
Dec 31, 2017	425.00K	-29.56M	-98.58%
Dec 31, 2016	29.98M	28.99M	2,928.38%
Dec 31, 2015	990.00K	-1.25M	-55.86%
Dec 31, 2014	2.24M	909.00K	68.14%
Dec 31, 2013	1.33M	-	-
Dec 31, 2012	-	-	-